GMRS earnings: next report 2026-09-07, real EPS beat/miss history, P/E 80.00. Updated 2026-07-23.
GMR Solutions (GMRS) Research Hub
GMR Solutions (GMRS) trades on NYSE, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-09-11, shares last closed at 12.78 USD (-2.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 80.00, market cap 0.61B. This hub links to the full technical, earnings and options research available for GMRS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NYSE, US |
| Last close | 12.78 USD (-2.29%) |
| 52-week range | 11.75 USD – 15.98 USD |
| Trend regime | Range |
| 14-day RSI | 51.3 (Neutral) |
| Trailing P/E | 80.00 |
| Market cap | 0.61B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-07 |
Available research for GMRS
Covered Call on GMRS: how it works, illustrative setup around the real 12.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GMRS: how it works, illustrative setup around the real 12.78 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GMRS: how it works, illustrative setup around the real 12.78 USD price, max profit/loss, breakeven and when to use it. Educational.
GMRS technical analysis: range, last 12.78 USD, RSI 51.3, 52w range 11.75 USD–15.98 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is GMRS in?
GMR Solutions (GMRS) is classified under Healthcare (Medical - Care Facilities), listed on NYSE, US.
Is GMRS in an uptrend or downtrend?
As of 2026-09-11, GMRS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GMRS's trailing P/E ratio?
GMRS's trailing P/E is 80.00, with a market cap of 0.61B. See the earnings research page for full valuation detail.
When does GMRS next report earnings?
GMRS is next scheduled to report earnings on 2026-09-07, with a consensus EPS estimate of 0.04 USD.